such as "Introduction", "Conclusion"..etc
Researchers in Finland are
reporting identification of the first potential “biomarker” that could be used
in development of a sputum test for early detection of chronic obstructive
pulmonary disease (COPD). That condition, which causes severe difficulty in
breathing — most often in cigarette smokers — affects 12 million people in the
an article scheduled for the December 5 issue of ACS’ Journal of Proteome Research, a monthly
publication, Vuokko L. Kinnula and colleagues point out that no disease marker
for COPD currently exists, despite extensive efforts by scientists to find one.
Past research pointed to a prime candidate — surfactant protein A (SP-A), which
has a major role in fighting infections and inflammation in the
scientists compared levels of a variety of proteins obtained from the lung
tissues of healthy individuals, patients with COPD, and those with pulmonary
fibrosis. They found that the lungs of COPD patients contained elevated levels
of SP-A. The scientists also found elevated levels of SP-A in the sputum samples
of COPD patients. “This suggests that SP-A might represent a helpful biomarker
in the early detection of COPD and other related disorders,” the article notes.
Source: News release from American Chemical Society (ACS) on December 3, 2008.
Enter the code exactly as it appears. All letters are case insensitive.